Waters Corporation delivered the strongest first-quarter performance among the ten research tools and consumables stocks tracked, with revenues of $1.27 billion, up 91.5% year on year and beating analysts' estimates by 4.5%. The company also posted the biggest analyst estimate beat, highest guidance raise, and fastest revenue growth among its peers. Avantor reported revenues of $1.58 billion, flat year on year but exceeding expectations by 2.7%, while Revvity's revenues of $686.9 million, up 9.3% year on year, fell short of estimates by 2.6% and came with full-year guidance that missed expectations. Sotera Health Company posted revenues of $280 million, up 10% year on year and topping estimates by 3.6%, and Bio-Techne reported revenues of $311.4 million, down 1.5% year on year and missing estimates by 1.6%. Overall, the group's revenues beat consensus estimates by 1.3%, and next-quarter revenue guidance was 2% above expectations, with share prices up 22.5% on average since the latest earnings results.
Waters CorporationWaters Corporation delivered the strongest Q1 performance with revenues of $1.27 billion, up 91.5% YoY, beating estimates by 4.5%, and posted the biggest analyst estimate beat and highest guidance raise.
Revvity Inc.Revvity's revenues of $686.9 million, up 9.3% YoY, fell short of estimates by 2.6% and full-year guidance missed expectations.
Avantor IncAvantor reported revenues of $1.58 billion, flat YoY but exceeding expectations by 2.7%.
Sotera Health CoSotera Health posted revenues of $280 million, up 10% YoY and topping estimates by 3.6%.
Bio-Techne CorpBio-Techne reported revenues of $311.4 million, down 1.5% YoY and missing estimates by 1.6%.